Clinical trial: the effects of a trans‐galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

Summary Background Gut microflora‐mucosal interactions may be involved in the pathogenesis of irritable bowel syndrome (IBS). Aim To investigate the efficacy of a novel prebiotic trans‐galactooligosaccharide in changing the colonic microflora and improve the symptoms in IBS sufferers. Methods In all... View More